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Human organic anion transporter 1 mediates cellular uptake of
cysteine-S conjugates of inorganic mercury.
Background. The epithelial cells lining the renal proximal
tubule have been shown to be the primary cellular targets where
mercuric ions gain entry, accumulate, and induce pathologic
effects in vivo. Recent data have implicated at least one of the
organic anion transport systems in the basolateral uptake of
inorganic mercury (Hg2+).
Methods. Using a line of Madin-Darby canine kidney
(MDCK) II cells transfected stably with the human organic an-
ion transporter 1 (hOAT1), and oocytes from Xenopus laevis
microinjected with cRNA for hOAT1, we tested the hypoth-
esis that hOAT1 can transport biologically relevant mercuric
conjugates of cysteine (Cys).
Results. Indeed, MDCK II cells expressing a functional
form of hOAT1 gained the ability to transport the mer-
curic conjugate 2-Amino-3-(2-amino-2-carboxy-ethylsulfanyl-
mercuricsulfanyl)-propionic acid (Cys-S-Hg-S-Cys), but not the
corresponding di-glutathione S-conjugate of Hg2+ (G-S-Hg-S-
G). Moreover, p-aminohippurate (PAH), adipate, and glutarate
(but not succinate or malonate) inhibited individually the up-
take of Cys-S-Hg-S-Cys in a dose-dependent manner. Uptake
of Cys-S-Hg-S-Cys, but not G-S-Hg-S-G, was also documented
in Xenopus oocytes expressing hOAT1.
Conclusion. These data represent ostensibly the most di-
rect line of evidence implicating a specific membrane protein
(i.e., hOAT1) in the transport of a biologically relevant molec-
ular species of Hg2+ in a mammalian cell. Moreover, these
data indicate that the organic anion transporter(s) likely play a
prominent role in the basolateral transport of mercuric ions by
proximal tubular cells and in the nephropathy induced by Hg2+.
Divalent cations of many heavy metals, such as mer-
cury, lead, cadmium, uranium, and others, have no known
nutritive or beneficial value in any mammalian cell. Yet
these metal-ions manage to gain entry into the cytosolic
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compartment of various target cells in the body under cer-
tain conditions and induce a host of deleterious effects,
largely by mechanisms that are poorly understood [1, 2].
A number of investigators have proposed that un-
bound cationic species of some of the smaller toxic heavy
metals can behave as ionic mimics (under the appropriate
conditions) at the sites of membrane-transporters and/or
channels involved in the cytosolic entry of essential ele-
ments (such as calcium, zinc, iron, etc.). It has also been
proposed that some of the more electrophilic cations form
stable conjugates or complexes (with various endogenous
biomolecules) that can behave as molecular “mimics” or
functional homologs of essential biomolecules (such as
amino acids, organic acids, dicarboxylates, etc.) at the sites
of membrane transporters involved in their uptake [2–4].
Mercuric ions are one group of cations that are be-
lieved to gain entry into target epithelial cells in mam-
malian organ systems by mechanisms involving molecu-
lar “mimicry” or homology [2–4]. In the kidneys, for ex-
ample, it has been proposed that the mercuric conjugate
of the amino acid cysteine (Cys) 2-Amino-3-(2-amino-
2-carboxy-ethylsulfanylmercuricsulfanyl)-propionic acid
(Cys-S-Hg-S-Cys) acts as a molecular homolog or
“mimic” of the amino acid cysteine (Cys-S-S-Cys) at the
site(s) of one or more amino acid transporters involved
in the luminal absorption of this amino acid along proxi-
mal tubular segments [2, 5, 6], which, coincidentally, are
primary regions of the nephron that take up and accumu-
late inorganic forms of mercury [7–9]. Support for this
hypothesis comes mainly from various indirect in vivo
findings and competitive inhibition data from isolated
perfused proximal tubular segments.
Interestingly, uptake of inorganic mercury (Hg2+) by
proximal tubular epithelial cells is not restricted to the
luminal plasma membrane. Various lines of evidence
(mainly from in vivo studies) indicate that mercuric ions
are also taken up from the blood and extracellular fluid at
their basolateral membrane, primarily in the form of one
or more mercuric conjugates of low-molecular-weight
thiols present in plasma. Moreover, a number of indi-
rect lines of evidence coming from recent in vivo and
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in vitro studies have implicated the organic anion
transport-system(s) in this basolateral transport of mer-
curic ions [10–16].
Within the kidneys, these transport-systems are lo-
calized exclusively along the proximal tubule (and par-
ticularly along the pars recta), and normally provide a
secretory mechanism for the elimination of many xeno-
biotics and endogenous organic anions that escape filtra-
tion during their passage through the kidney(s) [17]. One
of the best characterized organic anion transport-systems
mediates the basolateral uptake of a wide range of or-
ganic anions by a dicarboxylate/organic anion exchanger,
which has been denoted as organic anion transporter
1 (OAT1). This membrane protein transports organic
anions into the cytosolic compartment in exchange
for molecules of a-ketoglutarate. The intracellular-to-
extracellular gradient of a-ketoglutarate is maintained
by both intracellular metabolism and reclamation of a-
ketoglutarate from the extracellular compartment by
the sodium-coupled dicarboxylate transporter present
in the basolateral membrane of proximal tubular cells
[18].
Recent cloning studies have provided the sequence of
OAT1 in both rats [19, 20] and humans [21–24], and have
shown that OAT1 can mediate the uptake of a host of
low-molecular-weight and structurally dissimilar organic
acids and neutral compounds. Although OAT1 has been
implicated indirectly in the uptake of inorganic forms of
mercury, direct molecular evidence supporting a func-
tional role of this membrane protein in the transport of
Hg2+ in the form of a biologically relevant mercuric con-
jugate, such as Cys-S-Hg-S-Cys, is lacking.
Therefore, we designed experiments in the present
study to test the hypothesis that the dicarboxylate/organic
anion exchanger OAT1 (specifically the human isoform
hOAT1) is capable of transporting the biologically rele-
vant mercuric conjugate Cys-S-Hg-S-Cys into the intra-
cellular compartment of renal epithelial cells or Xenopus
laevis oocytes altered to express a functional form of this
membrane-protein. We also tested the hypothesis that
OAT1-mediated uptake of Cys-S-Hg-S-Cys is linked in
a causal manner to concentration- and time-dependent
induction of renal epithelial cell pathology.
The findings from the present study provide the most
comprehensive, direct line of evidence implicating a spe-
cific mammalian transporter in the cellular uptake of,
and induction of cellular injury by, a biologically relevant
molecular species of Hg2+.
METHODS
Transfection of MDCK II cells with hOAT1
A Mycoplasma-free, subclone of type II Madin-Darby
canine kidney (MDCK) cells was provided by Dr. Daniel
Balkovetz (University of Alabama at Birmingham). This
line was originally developed in the laboratory of Dr. Kai
Simmons (EMBL, Heidelberg). As described previously
by Aslamkhan et al [25, 26], these cells were transfected
with the cDNA for hOAT1 ligated to pcDNA3.1 (Invit-
rogen, Carlsbad, CA, USA) using Qiagen’s (Chatsworth,
CA, USA) SuperFect Reagent according to the manufac-
turer’s protocol (5 lL SuperFect/lg DNA). Subclones of
hOAT1-expressing (and wild-type) MDCK II cells used
in the present investigation were provided as a gift by
Dr. John Pritchard at National Institute of Environmen-
tal Health Sciences.
In our laboratory, cells expressing hOAT1 were main-
tained in culture media with 200 lg/mL geneticin (G418;
Invitrogen), and were screened regularly for gaining the
ability to transport organic anions by assaying uptake
of [3H]-PAH, as described below. OAT1-expressing cells
displaying the greatest level of [3H]-PAH uptake (greater
than 20× above that in nontransfected MDCK cells) were
used experimentally in the present study.
Cell culture
All transfected and wild-type MDCK II cells were
grown at 37◦C in Eagle’s minimum essential medium
(EMEM; Gibco BRL, Rockville, MD, USA) supple-
mented with 1 mmol/L sodium pyruvate and 10% fetal
bovine serum (FBS; Gibco BRL). The EMEM used to
grow the MDCK cells will hereafter be referred to as
“supplemented EMEM.” While in culture, the MDCK
cells were grown and maintained in a humidified atmo-
sphere consisting of 5% CO2 and 95% O2. Cells were split
every 3 to 7 days, and 1/10th to 1/20th of the culture was in-
oculated into new flasks. For each experiment, cells were
plated in 24-well (2.0 cm2 per well) cell-culture cluster-
plates (Costar Corning, NY, USA) containing supple-
mented EMEM, at a density of 0.5 × 106 cells per well
(added as 2 mL). All wild-type and hOAT1-expressing
cells used for transport and toxicity experiments were first
grown in culture for 48 hours to allow the cells to grow to
confluence. During this period of growth, the media was
changed after the first 24 hours of culture. Cell-to-cell
attachments afforded a low transepithelial resistance in
trans-well plates (12 mm in diameter having a pore-size
of 0.4 lm; Costar, Cambridge, MA, USA).
Uptake of PAH in hOAT1-transfected and
nontransfected MDCK II cells
At the time of experimentation, each well containing
cells was first rinsed with Hank’s balanced salt solution
(HBSS) supplemented with 10 mmol/L 4-(2-hydroxy-
ethyl)piperazine-1-ethanesulfonic acid (HEPES) (pH
7.4) for three consecutive five-minute periods. At the be-
ginning of each experiment, cells were incubated with
333 lL of the aforementioned Hank’s buffer contain-
ing 5 lmol/L PAH, with or without of 200 lmol/L
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probenecid, for 30 minutes. Some of the PAH was in
the form of 3H-PAH (4.54 mCi/lmol). At the end of a
particular exposure, the cells in each well were rinsed
with cold (4◦C) “stop” buffer [HBSS supplemented with
10 mmol/L HEPES (pH 7.4)]. Cellular content of 3H-
PAH was determined after adding 1 mL of 1N NaOH to
each well and shaking (in an orbital shaker at 500 rpm) for
24 hours. Seven hundred lL of cellular lysate from each
well were neutralized with 700 lL of 1N HCl. The total
volume of neutralized solution was added to 15 mL of
OPTI-FLOUR high flash-point liquid scintillation fluid
(Parkard Bioscience Co., Meriden, CT, USA). The ra-
dioactivity of each sample was determined using a
Beckman Scintillation Counter (Beckman Instruments,
Fullerton, CA, USA). Fifty lL of the remaining cellular
lysate from each well were used to determine the total
amount of protein per well using the Bradford protein
assay [3]. Transport data obtained from each well of cells
were normalized to the corresponding concentration of
cellular protein.
Uptake of Hg2+in hOAT1-transfected and
nontransfected MDCK II cells
Insertion of hOAT1 protein occurs at both apical
and basolateral plasma membranes in the MDCK cells
transfected with the cDNA encoding hOAT1 [1]. Api-
cal expression of hOAT1 permits one to study hOAT1-
dependent transport using cells grown on a solid surface.
Accordingly, cells were grown to confluence in 24-well
(2.0 cm2) cell culture-cluster plates (Costar Corning) con-
taining supplemented EMEM.
During the assessment of transport activity, media was
aspirated from the wells, and cells were rinsed three
times with 3 mL of HBSS supplemented with 10 mmol/L
HEPES (pH 7.4). Three hundred thirty-three lL of trans-
port buffer (specific to each experiment) containing ra-
dioactive 203Hg2+ were added to each well. In selective
experiments, competitive inhibitors of OAT1, such as
PAH or the dicarboxylates, adipate or glutarate, were
added to the transport buffer. Cys or GSH (which are
both present in the plasma of blood) was added in a
4:1 molar ratio to the concentration of mercuric cations
to ensure that each mercuric ion in solution formed a
thermodynamically stable, linear-II, coordinate-covalent
complex with two molecules of the respective thiol. The
association constant between mercuric ions and the sulfur
atom of low-molecular-weight thiols is more than 10 or-
ders of magnitude greater than that between mercuric
ions and any other biologically occurring nucleophilic
groups [2].
At the end of a particular exposure to one of the mer-
curic species studied, the cells in each well were rinsed
with cold (4◦C) “stop” buffer [HBSS supplemented
with 10 mmol/L HEPES (pH 7.4) containing 1 mmol/L
2,3-dimercaptopropane-1-sulfonic acid (DMPS) and
200 lmol/L probenecid]. DMPS is a very effective dithiol
chelator of mercuric ions. It was used to reduce the pool
of mercuric ions bound to outer surfaces of the plasma
membrane to negligible levels. Because DMPS oxidizes
rapidly in aqueous solutions, it was mixed into solution
within the first 15 minutes of its use. Probenecid was used
in the stop-buffer as added measure to inhibit the activity
of OAT1 at the termination of each experiment.
Cellular content of Hg2+ was determined using
both gamma-spectrometry and liquid scintillation spec-
troscopy. When liquid scintillation counting was em-
ployed, 1 mL of 1N NaOH was added to each well.
After adding the NaOH, the 24-well plates were shaken
in an orbital shaker at 500 rpm for 24 hours. Seven hun-
dred lL of cellular lysate from each well were neutralized
with 700 lL of 1N HCl. The total volume of neutralized
solution was added to 15 mL of OPTI-FLOUR high
flash-point liquid scintillation fluid (Packard Bioscience
Co.). The radioactivity of each sample was determined
using a Beckman LS6500 Liquid Scintillation Analyzer
(203Hg counting-efficiency 80% to 90%; Beckman In-
struments). Fifty lL of the remaining cellular lysate from
each well were used to determine the total amount of
protein per well using the Bradford protein-assay [27].
Transport data obtained from each well of cells were nor-
malized to the corresponding concentration of cellular
protein.
To determine if Cys-S-Hg-S-Cys is a transportable sub-
strate of hOAT1, dose-response data for the uptake of
Hg2+ (in the form of Cys-S-Hg-S-Cys) were fitted to the
Michaelis-Menten equation
V = Vmax[S]
Km + [S] (1)
In this equation, V represents velocity, Vmax is the
maximal velocity for transport of the substrate being
studied, [S] is the concentration of the substrate being
transported, and Km is the Michaelis-Menten constant.
Uptake of Hg2+ in oocytes expressing hOAT1
Female Xenopus laevis obtained from Xenopus One
(Ann Arbor, MI, USA) were used in the present study.
After a period of acclimation, the ovaries were removed
from a randomly selected number of frogs after they
had been anesthetized with triacin. Oocytes were then
isolated and defolliculated as described previously [25].
Briefly, this process employs digestion of connective tis-
sue with collagenase A (Roche Molecular Biochemi-
cals, Indianapolis, IN, USA), followed by incubation in a
K2HPO4-containing buffer. After isolation, the oocytes
were stored overnight in an incubator at 18◦C using an
oocyte Ringer’s 2 solution (OR-2; 82.5 mmol/L NaCl,
2.5 mmol/L KCl, 1 mmol/L Na2HPO4, 3 mmol/L NaOH,
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1 mmol/L CaCl2, 1 mmol/L MgCl2, 1 mmol/L Na-
pyruvate, 5 mmol/L HEPES, pH 7.6) supplemented
with 5% horse serum and 50 lg/mL gentamicin. After
overnight storage, stage IV and V oocytes were microin-
jected with 16.1 nL of either high-performance liquid
chromatography (HPLC)-grade water or capped RNA
(encoding hOAT1) at a concentration of 1.93 lg/lL.
Transport experiments with the oocytes were con-
ducted three days after injection. Before use, the oocytes
were separated into groups of 10 in 24-well plates and
were washed three times with 1 mL of unsupplemented
OR-2. Then, as with cellular transport-assays, 333 lL
of OR-2 containing 5 lmol/L Hg2+(containing 203Hg2+;
8.5 mCi/mg) and 20 lmol/L Cys or GSH were added to
each well and incubated for 1 hour at room temperature.
After incubation, oocytes were rinsed three times with
1 mL of ice-cold “stop buffer” composed of OR-2 sup-
plemented with 200 lmol/L probenecid and 1 mmol/L
DMPS (added to the buffer no more than 1 hour before
use). Oocytes were then lysed individually in 200 lL of
10% sodium dodecyl sulfate (SDS). After complete ly-
sis, 4 mL of EcoLumeTM scintillation fluid were added to
each vial, and the radioactivity of the samples was deter-
mined using by liquid scintillation spectroscopy using a
Beckman LS 6500 scintillation counter.
Assessment of toxicity and cellular viability
The effects of mercuric chloride (HgCl2) and Cys-S-
Hg-S-Cys on cellular viability were measured using a
methylthiazoletetrazolium (MTT)-based toxicology as-
say (Sigma Chemical Co., St. Louis, MO, USA). This
assay measures the activity of mitochondrial dehydro-
genase by the conversion of the yellow tetrazolium dye
MTT to purple formazan crystals. Cells were plated in
supplemented EMEM at a density of 5.0 × 104 cells/well
(added as 200 lL/well) in sterile 96-well microtiter plates
(Costar Corning), and allowed to grow for 48 hours in a
humidified atmosphere of 5% CO2, 95% air at 37◦C. Sup-
plemented EMEM was changed after the first 24 hours by
inversion. Excess media adhering to the plate was blot-
ted off with sterile gauze (Johnson & Johnson, Arlington,
TX, USA). After 48 hours, wells were again washed two
times with 200 lL of HBSS per well. After washing, test
compounds were added to individual wells (200 lL/well)
in unsupplemented EMEM, and cells were grown for
24 hours (unless otherwise specified) in a humidified at-
mosphere of 5% CO2, 95% O2 at 37◦C. At the conclusion
of the exposure period, media was removed by inversion
and blotting, wells were washed with 200 lL HBSS, and
100 lL of 0.5 mg/mL (1.2 mmol/L) MTT in HBSS was
added to each well. Cells were incubated for 2 hours, and
100 lL of solubilization buffer (10% Triton X-100, 0.1 N
HCl in isopropyl alcohol) were added to each well. This
buffer both lysed the cells (releasing the formazan) and
dissolved the water-insoluble formazan crystals. After an
overnight incubation at room temperature, full solubi-
lization occurred, and plates were read at 595 nm in a
Titertek Multiskan MKII plate reader (Fisher Scientific,
Suwanee, GA, USA).
Production of 203Hg2+
Three mg of mercuric oxide (HgO) containing the sta-
ble isotope 200Hg2+ and enriched 202Hg2+ (target) were
weighed and double-sealed in quartz tubing (actual mer-
curic oxide isotopic composition: <0.05% 196Hg, 1.5%
198Hg, 2.82% 199Hg, 4.24% 200Hg, 3.11% 201, 86.99%
202Hg, and 1.34% 204Hg). The double encapsulated target
was sent to the Missouri University Research Reactor
(MURR) facility to be irradiated (by neutron activation)
for four weeks. The irradiated target was placed in pro-
tected storage for 10 days to allow for the isotopic decay
of the newly formed 197Hg2+. The target was removed
from the quartz tubing with four 50-lL rinses of 1N HCl.
All four rinses were placed and sealed in a single 1.7-mL
polypropylene vial. A sample of the solution was then
used to determine the precise solid content of Hg us-
ing plasma-coupled elemental mass spectrometry. The
radioactivity of the solution was determined with a Wal-
lac Wizard 3′′ 1480 Automatic Gamma Counter (203Hg
counting-efficiency 50%; Gaithersburg, MD, USA).
The specific activities of the 203Hg2+ used in the present
study ranged between 8 to 12 mCi/mg Hg.
Statistical analysis
Results are presented as representative data from at
least two sets of experiments. Data are expressed as the
mean ± standard error. For uptake studies, a sample size
of N = 3 or 4 was used. Assuming that each sample was
mutually independent, statistical analysis for each param-
eter assessed was performed by first using a two-way anal-
ysis of variance (ANOVA) followed by either Tukey’s or
Dunnett’s post-hoc test. Data expressed as a percent were
first normalized using the arcsine transformation before
applying parametric statistical analyses. This transforma-
tion takes the arcsine of the square root of the decimal
fraction of the percent score. Differences among means
were considered statistically significant at P < 0.05.
RESULTS
Uptake of PAH
Confirmation that a functional hOAT1 transporter was
being inserted into the plasma membranes of the MDCK
II cells transfected with hOAT1 was achieved by assess-
ing uptake of 3H-PAH (a high-affinity substrate of this
organic anion/dicarboxylate exchanger) from the apical
membrane of cells grown on solid support. At an extracel-
lular concentration of 5 lmol/L, PAH was taken up from
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the extracellular environment into the cytosolic compart-
ment by the hOAT1-transfected MDCK cells at a rate
of 2.1 ± 0.6 pmol × min−1 × mg protein−1. Moreover,
addition of 200 lmol/L probenecid (a well established
inhibitor OAT1) to the extracellular media caused the
uptake of PAH in the transfected cells to be reduce to
0.21 ± 0.01 pmol × min−1 × mg protein−1, which is the
same level of PAH uptake/binding detected in the control
or nontransfected MDCK II cells. Furthermore, the very
low level of uptake/binding of PAH in the control cells
was not affected by the addition of probenecid to the
extracellular medium. Additional experiments utilizing
transwell-plates confirmed that uptake of PAH occurred
at both the luminal and basolateral membranes in con-
fluent monolayers of the transfected MDCK II cells, and
that this uptake could be inhibited by probenecid.
Based on these gain-of-function findings, it is clear that
a functional form of hOAT1 was indeed being inserted
into the plasma membranes of the transfected MDCK
cells.
Uptake Hg2+ in MDCK cells exposed to Cys-S-Hg-S-Cys
At all times studied, the rate of uptake of Hg2+ was
greater in the MDCK cells transfected with the cDNA
for hOAT1 than in the corresponding control cells when
they were exposed to 5 lmol/L Cys-S-Hg-S-Cys, with the
greatest differences detected at both 4 and 8 hours of ex-
posure (Fig. 1A). There was a slight increase in the con-
tent of Hg2+ associated with the control MDCK cells over
time, but this increase likely represents time-dependent
increases in nonspecific binding of Hg2+.
Uptake of Hg2+ as Cys-S-Hg-S-Cys in the hOAT1-
transfected cells had a Km of 91 ± 7 lmol/L and a Vmax
of 137 ± 4 pmol × min−1 × mg protein−1 (Fig. 1B). Very
little change in the uptake of Hg2+ was detected in the
control MDCK II cells over the range of concentrations
of Cys-S-Hg-S-Cys used.
It is clear from the assessment of both the time course
and the concentration dependence for the uptake of
Hg2+, in the form of Cys-S-Hg-S-Cys, that the MDCK
II cells gained the ability to transport Cys-S-Hg-S-Cys
subsequent to being transfected with hOAT1.
Effect of PAH on the uptake of Hg2+ in MDCK cells
When PAH was added to the extracellular compart-
ment, it inhibited the uptake of Hg2+, in the form of Cys-
S-Hg-S-Cys, in a concentration-dependent manner in the
hOAT1-transfected cells only (Fig. 2). By contrast, PAH
did not affect significantly the uptake of Hg2+ in the con-
trol cells when they were exposed to Cys-S-Hg-S-Cys.
Effect of dicarboxylates on the uptake of Hg2+ in
MDCK cells
Addition of 1 mmol/L adipate or glutarate (which are
exchangeable dicarboxylates at OAT1) to the extracellu-
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Fig. 1. Effect of time (A) and concentration (B) on the uptake of Hg2+
in control and hOAT1-expressing MDCK II cells exposed to the mer-
curic conjugate of cysteine Cys-S-Hg-S-Cys (at 37◦C). Values are mean
± SE. ∗Significantly different (P < 0.05) from the mean for the corre-
sponding group of control MDCK cells.
lar medium caused the uptake of Hg2+ (in the form of
Cys-S-Hg-S-Cys) in the transfected MDCK II cells to de-
crease to levels detected in corresponding control cells
(Fig. 3). By contrast, no significant reductions in the up-
take of Hg2+ were detected in the transfected MDCK
cells exposed to either 1 mmol/L malonate or 1 mmol/L
succinate (neither of which are exchangeable substrates
at OAT1).
No significant differences in the mean levels of uptake
or accumulation of Hg2+ were detected among the groups
of control MDCK II cells.
Uptake of Hg2+ in MDCK cells exposed to G-S-Hg-S-G
When either the transfected or control MDCK cells
were exposed to Hg2+, in the form of G-S-Hg-S-G, the
level of uptake of Hg2+ in both cell types was very low
(Fig. 4). More importantly, there was no significant differ-
ence in the uptake of Hg2+ between the two types of cells
exposed to this mercuric conjugate. Furthermore, addi-
tion of 1 mmol/L PAH to extracellular medium did not
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Fig. 2. Effect of p-aminohippurate (PAH)
on the uptake of Hg2+ in control and
hOAT1-expressing MDCK II cells exposed
for 60 minutes to the mercuric conjugate
of cysteine Cys-S-Hg-S-Cys (at 37◦C). Val-
ues are mean ± SE. ∗Significantly different
(P < 0.05) from the mean for the correspond-
ing group of MDCK cells exposed to only
5 lmol/L Cys-S-Hg-S-Cys. ∗∗Significantly dif-
ferent (P < 0.05) from the means for the cor-
responding groups of MDCK cells exposed
only to 5 lmol/L Cys-S-Hg-S-Cys or exposed
to 5 lmol/L Cys-S-Hg-S-Cys in the presence
of 10 lmol/L PAH. ∗∗∗Significantly different
(P < 0.05) from the means for the corre-
sponding groups of MDCK cells exposed only
to 5 lmol/L Cys-S-Hg-S-Cys or exposed to
5 lmol/L Cys-S-Hg-S-Cys in the presence of
10 or 20 lmol/L PAH.
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(P < 0.05) from the mean for the correspond-
ing group of MDCK cells not exposed to a di-
carboxylic acid or the corresponding groups
exposed to 1 mmol/L malonate or succinate.
significantly affect the level of uptake of Hg2+ in either
cell type.
Effect of temperature on the uptake of Hg2+
At 37◦C, uptake of Hg2+ in the transfected MDCK
cells exposed to 5 lmol/L Cys-S-Hg-S-Cys for one hour
was more than twofold greater than that in corre-
sponding control cells (Fig. 5). Transport activity in the
hOAT1-transfected cells was for the most part abolished
when the temperature of the extracellular medium was
reduced to either 21◦C or 4◦C. Moreover, reducing the
temperature of the extracellular medium revealed a slight
level of temperature-sensitive uptake of Hg2+ in the con-
trol MDCK cells (Fig. 5).
Uptake of Hg2+ in xenopus oocytes exposed
to Cys-S-Hg-S-Cys or G-S-Hg-S-G
Uptake of Hg2+ in the two groups of oocytes injected
with just water was very low during the one hour of
exposure to 5 lmol/L Cys-S-Hg-S-Cys or 5 lmol/L G-
S-Hg-S-G (Fig. 6). By contrast, the uptake of Hg2+ by
the oocytes injected with 30 ng of hOAT1-cRNA that
were exposed to 5 lmol/L Cys-S-Hg-S-Cys was more than
17-fold greater than that in the corresponding group of
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water-injected oocytes exposed to 5 lmol/L Cys-S-Hg-S-
Cys or the group of oocytes injected with hOAT1-cRNA
that were exposed to 5 lmol/L G-S-Hg-S-G. Moreover,
no significant difference was detected between the means
for the two groups of oocytes exposed to G-S-Hg-S-G for
one hour.
Assessment of toxicity and cellular viability
Significant decreases in survival of wild-type cells were
documented only in the cells exposed to mercuric chlo-
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cysteine, Cys-S-Hg-S-Cys, or the mercuric conjugate of glutathione, G-
S-Hg-S-G. Oocytes were either exposed to 5 lmol/L Cys-S-Hg-S-Cys
or 5 lmol/L G-S-Hg-S-G at room temperature for 60 minutes. Val-
ues are mean ± SE. ∗Significantly different (P < 0.05) from the mean
for the corresponding group of oocytes exposed to Cys-S-Hg-S-Cys.
+Significantly different (P < 0.05) from the mean for the correspond-
ing group of oocytes microinjected with cRNA for hOAT1 and exposed
to the same mercuric conjugate.
ride. At 100 and 200 lmol/L, less than 5% of the wild-
type cells survived 24 hours of exposure to the chloride
salt form of Hg2+ (Fig. 7A). Cellular viability was unaf-
fected among the wild-type cells exposed for 24 hours to
mercuric conjugates of Cys (from 5 to 200 lmol/L) for
24 hours.
By contrast, both forms of mercury diminished cellular
viability in the transfectants expressing hOAT1 (Fig. 7B).
Among the groups of transfectants exposed to mercuric
conjugates of Cys, significant changes in cellular viability
were detected at concentrations as low as 50 lmol/L. At
200 lmol/L, both forms of Hg2+ caused cellular survival
in the transfectants to decrease to below 20% during the
24 hours of exposure.
DISCUSSION
Because of the continuing worldwide contamination
of the environment with mercury and the increasing risk
of humans being exposed to various forms of mercury
[31], there is a growing need to better understand how
the various chemical forms of this metal are handled by
humans and other species of mammals. In order for one
to truly comprehend how mercury induces its deleterious
effects in a particular organism, it is paramount for one to
understand how mercury (in its many forms) gains entry
into the target cells it affects.
Over the past decade, a number of studies have been
carried out in an attempt to characterize the dispo-
sition and transport of mercury in target organs. The
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findings from a number of these studies have conclusively
documented that the kidneys are the primary sites in the
body where Hg2+ is taken up and accumulated [32], and
that the preponderance of this accumulation is linked to
the uptake of mercuric species by proximal tubular ep-
ithelial cells [2, 7–9]. More importantly, these findings
indicate that at least one luminal mechanism and at least
one basolateral mechanism are involved in the uptake
of mercury by proximal tubular epithelial cells [10–16,
28–31].
With the discovery that Hg2+ is taken up at the baso-
lateral membrane of proximal tubular epithelial cells in
vivo, it was determined that much of this uptake could be
inhibited by PAH [10, 11, 13, 15, 31]. Because PAH is a
high-affinity substrate of the dicarboxylate/organic anion
exchanger OAT1 [18, 32], it seemed logical for us to pos-
tulate that organic anion transporter(s) is/are involved in
the basolateral uptake of mercury [10–16, 28–31].
In the present study, we directly tested the hypothesis
that the membrane protein OAT1 (specifically hOAT1)
is capable of transporting biologically relevant molecular
species of mercury. We tested this hypothesis by char-
acterizing the transport of specific mercuric conjugates
in a line of MDCK II cells transfected stably with the
cDNA encoding the human isoform of the renal dicar-
boxylate/organic anion exchanger 1 (hOAT1). However,
before experimentation with mercuric conjugates, we first
established that expression and membrane insertion of
a fully functional hOAT1-protein was occurring in the
transfected MDCK II cells. This was accomplished by
demonstrating concentration- and time-dependent trans-
port of PAH, and by confirming the inhibitory effects of
probenecid or small dicarboxylates on the uptake of PAH
[1]. After we had established that a functional form of
hOAT1 was being inserted into the luminal plasma mem-
brane of the transfectants, we began to characterize the
transport of specific mercuric conjugates.
We discovered that when the MDCK II cells are trans-
fected with hOAT1, they not only gain the ability to
transport PAH, but they also gain the ability to transport
selective biomolecular species of Hg2+. More specifically,
they gain the ability to transport Hg2+ in the form of Cys-
S-Hg-S-Cys (and NAC-S-Hg-S-NAC [26]), from the ex-
tracellular fluid into their intracellular compartment. In
addition, we discovered that when oocytes from Xenopus
laevis are microinjected with cRNA encoding hOAT1,
they also gain the ability to transport Hg2+ in the form of
Cys-S-Hg-S-Cys into their cytosolic compartment. Col-
lectively, these findings clearly and convincingly demon-
strate that the mercuric conjugate Cys-S-Hg-S-Cys is in-
deed a transportable substrate of hOAT1. Furthermore,
the toxicologic findings from the transfectants show that
there is a direct, dose-dependent relationship between
the uptake of Cys-S-Hg-S-Cys by hOAT1 and the induc-
tion of cellular injury and death. The findings obtained
from the transfectants are particularly interesting inas-
much as MDCK cells (which are derived from the distal
nephron) are normally not cellular targets affected ad-
versely by biologically relevant forms of Hg2+. It should
be pointed out, however, that when either transfected
or control MDCK cells were exposed to the chloride
salt form of Hg2+, they became intoxicated, owing to
the tremendously toxic effects of mercuric ions in cul-
ture (when they are not covalently linked to the sulfur
atom of a thiol ligand). Overall, these data represent the
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Fig. 8. Diagrammatic representation of the mechanism by which OAT1 is involved in the basolateral uptake of Hg2+, in the form of mercuric
conjugates of cysteine (Cys), in a proximal tubular epithelial cell. In this representation, the intracellular concentration of a-ketoglutarate and the
extracellular concentrations of mercuric conjugates (or other substrates of OAT1) provide the energy to allow a-ketoglutarate to be transported
out of the proximal tubular epithelial cell in exchange for a mercuric conjugate of Cys by OAT1. This diagram also illustrates that known substrates
of OAT1 serve as competitive inhibitors for the uptake of mercuric conjugates of Cys at the site of OAT1. The three-dimensional, space-filled,
molecular models were generated in part with MOLPOV2 and Persistence of Vision (POV, version 3.5).
most direct line of evidence, to date, implicating a specific
mammalian protein (namely, hOAT1) in the transport of
biologically relevant molecular species of Hg2+.
Interestingly, only minimal levels of mercury (sim-
ilar to control levels) were associated with, or taken
up by, hOAT1-expressing MDCK II cells or oocytes
when these cells were exposed to mercuric S-conjugates
of GSH. These transport findings indicate that mer-
curic conjugates in the form of G-S-Hg-S-G are not
transportable substrates of OAT1. Normally, negatively
charged molecules containing 5 to 6 carbons appear to
have a particularly high affinity for OAT1 [18, 32–35].
Because G-S-Hg-S-G is much larger and bulkier than the
typical substrates of OAT1, the present findings are not
that surprising. What does make the findings perplex-
ing, though, are the various lines of evidence implicating
mercuric conjugates of GSH in the in vivo basolateral up-
take of Hg2+ by proximal tubular cells [15, 31, 36]. These
findings are also surprising because certain organic S-
conjugates of GSH have been implicated as substrates of
the organic anion transport system(s) [37–39]. It may be
that although mercuric S-conjugates of GSH are species
of mercury present in blood, the actual forms of Hg2+
transported by OAT1 (and other organic anion trans-
porters) are smaller, less sterically hindering forms of
mercury, such as mercuric conjugates of Cys.
A second class of inhibitors of OAT1 includes di-
carboxylates that exchange for organic anions at this
transporter. In vivo, generation (and maintenance) of
a downhill, intracellular-to-extracellular gradient of a-
ketoglutarate serves to facilitate the transport of organic
anions into the cytosolic compartment of proximal tubu-
lar cells by a molecular exchange mechanism mediated
by OAT1 [18, 32–35]. Other dicarboxylates, especially
molecular homologs of a-ketoglutarate, such as adipate
and glutarate, have been shown to compete for OAT1. In
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contrast, the four-carbon dicarboxylate succinate is not
an effective inhibitor of OAT1 [37]. In a recent study,
[16] it was demonstrated that both adipate and glutarate,
but not succinate or malonate (3-carbon atoms long), in-
hibited (in a dose-dependent manner) the uptake of in-
travenously administered Hg2+ in rats. These findings are
in complete agreement with those of the present investi-
gation. The current findings also establish that the uptake
of PAH or Cys-S-Hg-S-Cys in cells expressing hOAT1 are
inhibited by adipate or glutarate, but not by succinate or
malonate (Figs. 3 and 8). These findings, therefore, serve
as additional evidence implicating mercuric S-conjugates
of Cys as transportable substrates of OAT1.
Much like any membrane transporter, the basis for
transport at hOAT1 is greatly dependent on molecu-
lar structure-function relationships that exist between
the transporter and substrate [17]. Molecular homology
among substrates likely plays an important role in the ac-
tivity of OAT1. Molecular homology is implicated in the
transport of these conjugates because they share struc-
tural and/or functional characteristics common to other
mercapturic acids that are known to be substrates of
hOAT1 [40]. The present findings also implicate molec-
ular homology in that Cys-S-Hg-S-Cys is a molecular
homolog of NAC-S-Hg-S-NAC, which we have shown
recently to be a transportable substrate of hOAT1 [26].
We were also able to show a correlation between the rates
of uptake of NAC-S-Hg-S-NAC and the induction of cel-
lular injury and death in the hOAT1-expressing cells [26].
Even though Cys has a net neutral charge in blood, cer-
tain organic S-conjugates of Cys have been implicated as
transportable substrates of OAT1 [33, 39, 41]. Thus, based
on the aforementioned findings, mercuric conjugates of
Cys and its homolog NAC make up a class of homologous
molecules that are substrates of hOAT1.
Because Cys and GSH are present in the blood of hu-
mans and other mammals at low lmol/L concentrations
[42–45], mercuric conjugates of these low-molecular-
weight thiols are believed to be the most biologically rele-
vant forms of Hg2+ (in addition to mercuric conjugates of
albumin) that are presented to proximal tubular epithe-
lial cells in vivo. It is during the initial hours after exposure
that as much as 50% of a dose of Hg2+ is taken up by the
proximal tubular segments through luminal and basolat-
eral mechanisms. There is presently insufficient evidence
to speculate whether mercuric conjugates of NAC are
present in the blood before and/or after exposure to the
various forms of Hg2+.
CONCLUSION
The present findings represent the first line of direct
evidence implicating a specific membrane protein (i.e.,
hOAT1) in the transport and cellular intoxication of spe-
cific, biologically relevant, molecular species of Hg2+ in
a mammalian cell. More importantly, these data indicate
that OAT1 likely plays an important role in the baso-
lateral uptake of mercuric ions along the renal proximal
tubule, and that molecular homology/mimicry is involved
in this process. Figure 8 provides a diagrammatic sum-
mary of the putative role of OAT1 in the basolateral
uptake of Cys-S-Hg-S-Cys in a proximal tubular cell. Fur-
thermore, they also indicate that the basolateral uptake of
mercuric conjugates of Cys by OAT1 is linked directly to
the proximal tubular nephropathy induced by inorganic
forms of mercury in vivo.
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